Because Mounjaro mimics GLP-1 and GIP, it helps control appetite, making you feel more full and less hungry
Immune System Modulation Several peptides are being investigated for their immunomodulatory properties
What This Means for Women in Midlife If you're considering a GLP-1 medication for weight management, the question isn't just "which medication?" it's "what else is going on hormonally?" For women in perimenopause or postmenopause, addressing estrogen deficiency may: Enhance the weight loss response to GLP-1 medications [1] Improve the metabolic benefits including better insulin sensitivity and reduced visceral fat [7, 8] Address symptoms like sleep disruption, hot flashes, and mood changes that can undermine weight loss efforts [10] Support long-term cardiovascular health during a period of accelerated risk [9] This is why a comprehensive approach one that evaluates both your metabolic health and your hormonal status matters so much more than choosing a single medication in isolation
And I think with obesity, it might work the same way once we have greater numbers of choices in the clinic
I have been conducting research into the psychosocial determinants of obesity-related behaviours and the lived experience of obesity for over 16 years
In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dG
